Furuhata Masanori, Yanagisawa Naoki, Nishiki Shingo, Sasaki Shugo, Suganuma Akihiko, Imamura Akifumi, Ajisawa Atsushi
Department of Infectious Diseases, Tokyo Metropolitan Komagome Hospital, Japan.
Intern Med. 2016;55(24):3671-3674. doi: 10.2169/internalmedicine.55.7169. Epub 2016 Dec 15.
We herein report the case of a 25-year-old man who was referred to our hospital due to acute cytomegalovirus (CMV) colitis. The initial blood tests showed that the patient had concurrent primary human immunodeficiency virus (HIV) infection and severe thrombocytopenia. Raltegravir-based antiretroviral therapy (ART) was initiated without the use of ganciclovir or corticosteroids and resulted in a rapid clinical improvement. Platelet transfusions were only necessary for a short period, and subsequent colonoscopy revealed a completely healed ulcer. This case implies that ART alone could be effective for treating severe thrombocytopenia during primary HIV and CMV coinfection.
我们在此报告一例25岁男性患者,因急性巨细胞病毒(CMV)结肠炎转诊至我院。初始血液检查显示该患者同时感染了原发性人类免疫缺陷病毒(HIV)且患有严重血小板减少症。在未使用更昔洛韦或皮质类固醇的情况下启动了基于拉替拉韦的抗逆转录病毒疗法(ART),并取得了迅速的临床改善。仅在短时间内需要进行血小板输注,随后的结肠镜检查显示溃疡完全愈合。该病例表明,单独使用ART可能对治疗原发性HIV和CMV合并感染期间的严重血小板减少症有效。